Aarabi Bizhan, Hesdorffer Dale C, Ahn Edward S, Aresco Carla, Scalea Thomas M, Eisenberg Howard M
Department of Neurosurgery and R Adams Cowley Shock Trauma Center, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA.
J Neurosurg. 2006 Apr;104(4):469-79. doi: 10.3171/jns.2006.104.4.469.
The aim of this study was to assess outcome following decompressive craniectomy for malignant brain swelling due to closed traumatic brain injury (TBI).
During a 48-month period (March 2000-March 2004), 50 of 967 consecutive patients with closed TBI experienced diffuse brain swelling and underwent decompressive craniectomy, without removal of clots or contusion, to control intracranial pressure (ICP) or to reverse dangerous brain shifts. Diffuse injury was demonstrated in 44 patients, an evacuated mass lesion in four in whom decompressive craniectomy had been performed as a separate procedure, and a nonevacuated mass lesion in two. Decompressive craniectomy was performed urgently in 10 patients before ICP monitoring; in 40 patients the procedure was performed after ICP had become unresponsive to conventional medical management as outlined in the American Association of Neurological Surgeons guidelines. Survivors were followed up for at least 3 months posttreatment to determine their Glasgow Outcome Scale (GOS) score. Decompressive craniectomy lowered ICP to less than 20 mm Hg in 85% of patients. In the 40 patients who had undergone ICP monitoring before decompression, ICP decreased from a mean of 23.9 to 14.4 mm Hg (p < 0.001). Fourteen of 50 patients died, and 16 either remained in a vegetative state (seven patients) or were severely disabled (nine patients). Twenty patients had a good outcome (GOS Score 4-5). Among 30-day survivors, good outcome occurred in 17, 67, and 67% of patients with postresuscitation Glasgow Coma Scale scores of 3 to 5, 6 to 8, and 9 to 15, respectively (p < 0.05). Outcome was unaffected by abnormal pupillary response to light, timing of decompressive craniectomy, brain shift as demonstrated on computerized tomography scanning, and patient age, possibly because of the small number of patients in each of the subsets. Complications included hydrocephalus (five patients), hemorrhagic swelling ipsilateral to the craniectomy site (eight patients), and subdural hygroma (25 patients).
Decompressive craniectomy was associated with a better-than-expected functional outcome in patients with medically uncontrollable ICP and/or brain herniation, compared with outcomes in other control cohorts reported on in the literature.
本研究旨在评估因闭合性颅脑损伤(TBI)导致恶性脑肿胀而行去骨瓣减压术后的结果。
在48个月期间(2000年3月至2004年3月),967例闭合性TBI连续患者中有50例发生弥漫性脑肿胀并接受了去骨瓣减压术,未清除血块或挫伤灶,以控制颅内压(ICP)或纠正危险的脑移位。44例患者显示为弥漫性损伤,4例患者有已清除的占位性病变,这4例患者中去骨瓣减压术作为单独的手术进行,2例患者有未清除的占位性病变。10例患者在进行ICP监测之前紧急实施了去骨瓣减压术;40例患者在ICP对美国神经外科医师协会指南中所述的传统药物治疗无反应后实施了该手术。对幸存者进行至少3个月的治疗后随访,以确定其格拉斯哥预后评分(GOS)。去骨瓣减压术使85%的患者ICP降至20 mmHg以下。在减压前进行ICP监测的40例患者中,ICP从平均23.9 mmHg降至14.4 mmHg(p<0.001)。50例患者中有14例死亡,16例处于植物状态(7例患者)或严重残疾(9例患者)。20例患者预后良好(GOS评分4 - 5)。在30天幸存者中,复苏后格拉斯哥昏迷量表评分为3至5分、6至8分和9至15分的患者中,分别有17%、67%和67%预后良好(p<0.05)。瞳孔对光反应异常、去骨瓣减压术的时机、计算机断层扫描显示的脑移位以及患者年龄均未影响预后,可能是因为每个亚组中的患者数量较少。并发症包括脑积水(5例患者)、去骨瓣减压术部位同侧的出血性肿胀(8例患者)和硬膜下积液(25例患者)。
与文献报道的其他对照队列的结果相比,去骨瓣减压术与药物无法控制ICP和/或脑疝患者的功能预后优于预期相关。